Latest Products
Impact of the COVID-19 Pandemic on the Revenue of Large Medical Device Companies
Release time:
2025-03-12 09:42
We have seen that the novel coronavirus pneumonia has caused a more serious public health threat in China than SARS, and the impact of the epidemic on the medical industry is gradually becoming apparent.
According to foreign media analysis, as China mobilizes a large amount of manpower and medical resources to fight the epidemic, non-emergency medical surgeries have rapidly decreased. This means that multinational medical device companies operating locally, including Medtronic and Boston Scientific, will have lower-than-expected revenue this quarter.
Currently, China's entire medical system is committed to curbing the spread of the novel coronavirus. Data shows that the surgery volume of these large medical device companies is declining, resulting in lower-than-expected revenue in Q1. Furthermore, potential supply chain disruptions could further affect the revenue growth of some medical device companies.
According to the Boston Scientific earnings call record from early February, the company expects a $10 million to $40 million decrease in first-quarter revenue.
Boston Scientific CFO Dan Brennan stated, "While we are still in the early stages of assessing the impact and highly value and support our patients and employees in China, the prudent approach is to factor in the potential impact of the novel coronavirus on our first-quarter revenue."
He said that Boston Scientific may regain some of the previously lost surgeries in the remainder of the year and offset some of the previous impacts related to the novel coronavirus.
In the Tel conference, answering a question from an analyst, he said, "Fortunately, our business portfolio in China is very diversified; it does not rely on any specific business. Our team is also reflecting on the situation here. Obviously, the vast majority of medical resources in China are concentrated on the prevention, diagnosis, and treatment of the novel coronavirus, and all surgeries may be postponed."
Medtronic, the world's largest medical device company, has a similar situation. On February 18, in a call with investors, Medtronic CEO Omar Ishrak also admitted that the company's business in China has slowed down due to the spread of the novel coronavirus, but he did not disclose any figures.
“We expect this to affect our Q4 financial Achievements, but given that the epidemic is still changing, it is difficult to quantify the duration and extent of the impact at present,” he said.
At the same time, Omar Ishrak pointed out that Medtronic's production and operations in China are operating normally. He emphasized that Medtronic's biggest concern is not its Achievements but the health and well-being of its employees in China and around the world.
Company, we, China, impact, medical, virus, income, medical devices, surgery